Secchiero, P, Carrigan, D R, Asano, Y et al. · The Journal of infectious diseases · 1995 · DOI
Researchers developed a sensitive test to detect human herpesvirus 6 (HHV-6) DNA in blood. They tested blood samples from children with a specific rash illness, bone marrow transplant patients, HIV-infected patients, people with chronic fatigue syndrome (ME/CFS), and healthy adults. The test found HHV-6 DNA most often in children with the rash illness, less commonly in transplant and HIV patients, rarely in ME/CFS patients, and not at all in healthy people.
This study is relevant to ME/CFS research because it provides one of the earliest systematic attempts to detect active HHV-6 infection in ME/CFS patients using molecular methods. The very low detection rate (2.6%) in ME/CFS patients compared to primary infection controls helps establish baseline data on HHV-6 prevalence in this population and informs subsequent investigations into whether HHV-6 plays a significant role in ME/CFS.
This study does not prove that HHV-6 causes or contributes to ME/CFS, as the low detection rate in ME/CFS patients (1/39) actually suggests HHV-6 is not commonly active during the illness. The cross-sectional design cannot establish temporal relationships or determine whether any detected virus is causative versus coincidental. The study also does not distinguish between latent infection and active replication or clarify the clinical significance of positive results.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →